Bisphosphonates linked to osteonecrosis of the jawBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7580.1213-a (Published 07 December 2006) Cite this as: BMJ 2006;333:1213
For more than a decade bisphosphonates have been widely used to control bony metastases and to prevent and treat osteoporosis, among other things. So far, they have had a good safety profile, with the possible exception of some isolated case reports of osteonecrosis of the jaw. …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial